The impact of the introduction of bortezomib on dialysis independence in multiple myeloma patients with renal impairment: a nationwide Dutch population-based study

• Berdien E. Oortgiesen,
• Roshna Azad,
• Marc H. Hemmelder,
• Robby E. Kibbelaar,
• Nic J.G.M. Veeger,
• Joost C. de Vries,
• Eric N. van Roon,
• Mels Hoogendoorn

Affiliations

Berdien E. Oortgiesen

Department of Clinical Pharmacy and Pharmacology, Medical Center Leeuwarden, the Netherlands

Roshna Azad

Department of Clinical Pharmacy and Pharmacology, Medical Center Leeuwarden, the Netherlands

Marc H. Hemmelder

Department of Nephrology, Medical Center Leeuwarden, the Netherlands

Robby E. Kibbelaar

Department of Pathology, Pathology Friesland, Leeuwarden, the Netherlands

Nic J.G.M. Veeger

Department of Epidemiology, MCL Academy, Leeuwarden, the Netherlands;Department of Epidemiology, University of Groningen, University Medical Center Groningen, the Netherlands

Joost C. de Vries

Department of Hematology, Medical Center Leeuwarden, the Netherlands

Eric N. van Roon

Unit of Pharmacotherapy, Epidemiology and Economics, Department of Pharmacy, University of Groningen, the Netherlands

Mels Hoogendoorn

Department of Hematology, Medical Center Leeuwarden, the Netherlands